Denali Therapeutics
DNLI
#4389
Rank
C$2.43 B
Marketcap
$16.75
Share price
-7.90%
Change (1 day)
-34.88%
Change (1 year)

Earnings for Denali Therapeutics (DNLI)

Earnings in 2024 (TTM): -C$0.7 Billion

According to Denali Therapeutics 's latest financial reports the company's current earnings are N/A. a decrease over its 2023 earnings that were of -C$0.28 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Denali Therapeutics from 2017 to 2024

Annual earnings

Year Earnings Change
2024 -C$0.72 Billion155.15%
2023 -C$0.28 Billion-42.27%
2022 -C$0.49 Billion15.21%
2021 -C$0.43 Billion-571.56%
2020 C$89.17 M-129.42%
2019 -C$0.31 Billion359.73%
2018 -C$65.94 Million-48.56%
2017 -C$0.13 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-C$0.18 Billion-75.93% Jersey
-C$0.23 Billion-68.81%๐Ÿ‡บ๐Ÿ‡ธ USA
-C$17.61 Million-97.53%๐Ÿ‡บ๐Ÿ‡ธ USA
-C$0.11 Billion-85.44%๐Ÿ‡ฌ๐Ÿ‡ง UK